Journal of personalized nanomedicine最新文献

筛选

英文中文

Macrophage Targeted Nanoparticles for Antiretroviral (ARV) Delivery. 用于递送抗逆转录病毒 (ARV) 的巨噬细胞靶向纳米颗粒。

Journal of personalized nanomedicine Pub Date : 2015-11-01 Epub Date: 2015-11-14

Hilliard L Kutscher, Faithful Makita-Chingombe, Sara DiTursi, Ajay Singh, Admire Dube, Charles C Maponga, Gene D Morse, Jessica L Reynolds

{"title":"Macrophage Targeted Nanoparticles for Antiretroviral (ARV) Delivery.","authors":"Hilliard L Kutscher, Faithful Makita-Chingombe, Sara DiTursi, Ajay Singh, Admire Dube, Charles C Maponga, Gene D Morse, Jessica L Reynolds","doi":"","DOIUrl":"","url":null,"abstract":"Objective: To reduce the amount of the antiretroviral (ARV) nevirapine necessary to achieve therapeutic concentrations using macrophage targeted nanoparticles.Methods: Core-shell nanoparticles were prepared from FDA approved, biodegradable and biocompatible polymers, with poly(lactic-co-glycolic) acid (PLGA) as the core and chitosan (CS) as the shell using a water/oil/water method. Nevirapine was encapsulated in the core of the nanoparticles. β-glucan (GLU) was adsorbed to the surface of the nanoparticle. Macrophage uptake and intracellular nevirapine concentrations were determined by fluorescence imaging and ultra-performance liquid chromatography/mass spectroscopy (UPLC-MS). Optical imaging was employed to characterize the biodistribution of nanoparticles following intravenous injection in CD-1 mice.Results: We synthesized spherical shaped 190 nm GLU-CS-PLGA nanoparticles that provide controlled release of nevirapine. In THP-1 macrophage the uptake of PLGA and CS- PLGA nanoparticles was less compared to targeted GLU-CS-PLGA nanoparticles. THP-1 macrophage were dosed with free nevirapine (10 μg/well) and GLU-CS- PLGA nanoparticles containing 1/10 the concentration of free nevirapine (1 μg nevirapine/well). The intracellular concentration of nevirapine was the same for both nanoparticles and free nevirapine at 2 and 24 hrs. No significant change in THP-1 macrophage viability was observed in the presence of nanoparticles relative to the control. Ex vivo imaging demonstrates that nanoparticles are predominantly found in the liver and kidney and at 24 hr there is still a large amount of nanoparticles in the body.Conclusion: These data demonstrate that the total dose of nevirapine delivered by GLU-CS-PLGA nanoparticles can be greatly reduced, to limit side effects, while still providing maximal ARV activity in a known cellular reservoir.","PeriodicalId":91128,"journal":{"name":"Journal of personalized nanomedicine","volume":"1 2","pages":"40-48"},"PeriodicalIF":0.0,"publicationDate":"2015-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5826576/pdf/nihms859399.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35873868","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Nanostructured Gas Sensors for Health Care: An Overview. 用于医疗保健的纳米结构气体传感器：概述。

Journal of personalized nanomedicine Pub Date : 2015-07-01 Epub Date: 2015-07-27

Ajeet Kaushik, Rajesh Kumar, Rahul Dev Jayant, Madhavan Nair

引用次数: 0